Italy · Delayed Price · Currency is EUR Philogen Statistics
Total Valuation
Philogen has a market cap or net worth of EUR 910.36 million. The enterprise value is 542.06 million.
| Market Cap | 910.36M |
| Enterprise Value | 542.06M |
Important Dates
The last earnings date was Wednesday, September 23, 2026.
| Earnings Date | Sep 23, 2026 |
| Ex-Dividend Date | May 18, 2026 |
Share Statistics
Philogen has 40.28 million shares outstanding.
| Current Share Class | 28.91M |
| Shares Outstanding | 40.28M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 3.23% |
| Float | 10.74M |
Valuation Ratios
The trailing PE ratio is 4.05.
| PE Ratio | 4.05 |
| Forward PE | n/a |
| PS Ratio | 2.89 |
| PB Ratio | 2.74 |
| P/TBV Ratio | 2.75 |
| P/FCF Ratio | 3.47 |
| P/OCF Ratio | 3.44 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.13, with an EV/FCF ratio of 2.07.
| EV / Earnings | 2.41 |
| EV / Sales | 1.72 |
| EV / EBITDA | 2.13 |
| EV / EBIT | 2.17 |
| EV / FCF | 2.07 |
Financial Position
The company has a current ratio of 0.36
| Current Ratio | 0.36 |
| Quick Ratio | 0.28 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 37.68 |
Financial Efficiency
Return on equity (ROE) is 98.35% and return on invested capital (ROIC) is 66.36%.
| Return on Equity (ROE) | 98.35% |
| Return on Assets (ROA) | 57.38% |
| Return on Invested Capital (ROIC) | 66.36% |
| Return on Capital Employed (ROCE) | 74.56% |
| Weighted Average Cost of Capital (WACC) | 4.15% |
| Revenue Per Employee | 1.47M |
| Profits Per Employee | 1.05M |
| Employee Count | 214 |
| Asset Turnover | 1.16 |
| Inventory Turnover | 11.73 |
Taxes
In the past 12 months, Philogen has paid 30.01 million in taxes.
| Income Tax | 30.01M |
| Effective Tax Rate | 11.77% |
Stock Price Statistics
The stock price has decreased by -3.00% in the last 52 weeks. The beta is -0.02, so Philogen's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | -3.00% |
| 50-Day Moving Average | 23.41 |
| 200-Day Moving Average | 22.59 |
| Relative Strength Index (RSI) | 41.64 |
| Average Volume (20 Days) | 18,151 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Philogen had revenue of EUR 315.27 million and earned 224.98 million in profits.
| Revenue | 315.27M |
| Gross Profit | 272.92M |
| Operating Income | 249.46M |
| Pretax Income | 254.99M |
| Net Income | 224.98M |
| EBITDA | 252.85M |
| EBIT | 249.46M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 331.69M |
| Book Value Per Share | n/a |
| Working Capital | -31.55M |
Cash Flow
In the last 12 months, operating cash flow was 264.45 million and capital expenditures -2.04 million, giving a free cash flow of 262.41 million.
| Operating Cash Flow | 264.45M |
| Capital Expenditures | -2.04M |
| Depreciation & Amortization | 3.39M |
| Net Borrowing | -1.43M |
| Free Cash Flow | 262.41M |
| FCF Per Share | 6.51 |
Margins
Gross margin is 86.57%, with operating and profit margins of 79.13% and 71.36%.
| Gross Margin | 86.57% |
| Operating Margin | 79.13% |
| Pretax Margin | 80.88% |
| Profit Margin | 71.36% |
| EBITDA Margin | 80.20% |
| EBIT Margin | 79.13% |
| FCF Margin | 83.23% |
Dividends & Yields
This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 3.10%.
| Dividend Per Share | 0.70 |
| Dividend Yield | 3.10% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 12.52% |
| FCF Payout Ratio | 10.75% |
| Buyback Yield | n/a |
| Shareholder Yield | 3.10% |
| Earnings Yield | 24.71% |
| FCF Yield | 28.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for Philogen is 27.67, which is 22.43% higher than the current price. The consensus rating is "Buy".
| Price Target | 27.67 |
| Price Target Difference | 22.43% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | -36.76% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |